CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,924,000 | -41.2% | 203,332 | -64.0% | 0.01% | -45.0% |
| Q2 2017 | $6,672,000 | -26.2% | 565,390 | -31.4% | 0.02% | -25.9% |
| Q1 2017 | $9,039,000 | +49.3% | 824,752 | -1.1% | 0.03% | +50.0% |
| Q4 2016 | $6,054,000 | +357.9% | 833,919 | +309.8% | 0.02% | +350.0% |
| Q3 2016 | $1,322,000 | – | 203,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |